Intranasal Corticosteroid
Pregnancy: Compatible — minimal systemic absorption
Fluticasone Propionate Nasal Spray
Brand names: Flixonase, Pirinase (OTC)
Adult dose
Dose: 200 mcg (2 sprays/nostril) OD or 50 mcg (1 spray/nostril) BD. Maintenance: 100 mcg (1 spray/nostril) OD.
Route: Intranasal
Frequency: OD–BD
Max: 400 mcg/day
For allergic and non-allergic rhinitis, nasal polyps. Available OTC (Pirinase 50 mcg). Takes 3–7 days for symptom relief. Consistent daily use required.
Paediatric dose
Route: Intranasal
Frequency: OD
Max: 100 mcg OD (4–11 years); 200 mcg OD (≥12 years)
Concentration: 50 mcg/spray mcg/ml
Children ≥4 years: 50 mcg (1 spray) per nostril OD. Not for children <4 years. Review regularly — use lowest effective dose.
Dose adjustments
Renal
N/A
Hepatic
N/A
Clinical pearls
- Ritonavir interaction: potent CYP3A4 inhibitor dramatically increases systemic fluticasone — use beclometasone or mometasone instead in patients on ritonavir-containing HIV regimens
- Spray technique: aim away from nasal septum (towards outer nasal wall) to avoid septal perforation
- Epistaxis: frequent — use Vaseline on anterior septum; if persistent, switch to aqueous spray
- OTC availability as Pirinase — patients can self-manage seasonal allergic rhinitis
Contraindications
- Untreated nasal infection
Side effects
- Epistaxis (most common)
- Nasal dryness and irritation
- Headache
- Nasal septal perforation (rare, incorrect technique — spray away from septum)
Interactions
- Ritonavir — increases systemic fluticasone exposure (Cushing's syndrome risk — avoid combination)
Monitoring
- Symptom control
- Epistaxis
- Nasal septal inspection (prolonged use)
Reference: BNFc; BNF; NICE NG174 Allergic Rhinitis; BAO-HNS Rhinitis Guidelines. Verify against your local formulary and the latest BNF before prescribing.
Related
Curated clinical cross-links plus same-class fallbacks.
Calculators
Drugs
Pathways
- Adult Upper Airway Obstruction (Stridor) · DAS 2015 unanticipated difficult airway; RCEM
- Epistaxis Management · ENT-UK / NICE
- Acute Otitis Media · NICE NG91 2018
- Tonsillitis and Sore Throat · NICE NG84 2018
- Benign Paroxysmal Positional Vertigo · NICE CG124 / AAO-HNS Guidelines
- Acute Rhinosinusitis · NICE NG79 2017 / EPOS 2020